Presentation TCT 2012 TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3... Presenter: Peter Smits October 23, 2012
Presentation TCT 2012 TCT-53. Assessment of 30-day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A... Presenter: Jay Bae October 23, 2012
Presentation TCT 2012 Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step! Presenter: Juan Granada October 23, 2012
Presentation TCT 2012 Yes: The Quantitative Threshold Should Be Lowered! Presenter: Maurice Sarano October 23, 2012
Presentation TCT 2012 Circulatory Support for Cardiogenic Shock Presenter: E. Magnus Ohman October 23, 2012
Presentation TCT 2012 TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group... Presenter: Rasha Al-Lamee October 23, 2012
Presentation TCT 2012 CT and MRI for Patient Selection and Procedural Guidance Presenter: Carlos Ruiz October 23, 2012
Presentation TCT 2012 TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients Presenter: Klaudija Bijuklic October 23, 2012
Presentation TCT 2012 Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices Presenter: Juan Granada October 23, 2012